DK1353688T3 - Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet - Google Patents
Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenetInfo
- Publication number
- DK1353688T3 DK1353688T3 DK02706015T DK02706015T DK1353688T3 DK 1353688 T3 DK1353688 T3 DK 1353688T3 DK 02706015 T DK02706015 T DK 02706015T DK 02706015 T DK02706015 T DK 02706015T DK 1353688 T3 DK1353688 T3 DK 1353688T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- psedomonas
- immunization
- compositions
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/770,916 US6827935B2 (en) | 1998-11-25 | 2001-01-26 | Method of and compositions for immunization with the pseudomonas V antigen |
US26479501P | 2001-01-29 | 2001-01-29 | |
PCT/US2002/002382 WO2002064161A2 (en) | 2001-01-26 | 2002-01-25 | Method and compositions for immunization with the pseudomonas v antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1353688T3 true DK1353688T3 (da) | 2007-04-10 |
Family
ID=26950766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02706015T DK1353688T3 (da) | 2001-01-26 | 2002-01-25 | Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet |
Country Status (8)
Country | Link |
---|---|
US (2) | US7494653B2 (de) |
EP (1) | EP1353688B1 (de) |
JP (1) | JP4355786B2 (de) |
AT (1) | ATE347374T1 (de) |
DE (1) | DE60216564T2 (de) |
DK (1) | DK1353688T3 (de) |
ES (1) | ES2275840T3 (de) |
WO (1) | WO2002064161A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2784450C (en) * | 2001-11-13 | 2016-09-13 | Id Biomedical Corporation | Polypeptides of pseudomonas aeruginosa |
EP1790659B1 (de) * | 2001-11-13 | 2013-07-31 | ID Biomedical Corporation | Pseudomonas aeruginosa Polypeptide |
JP2007509837A (ja) | 2003-08-01 | 2007-04-19 | 中国医学科学院基礎医学研究所 | 多価エピトープキメラ遺伝子ワクチンの製法 |
US20090208535A1 (en) * | 2004-06-28 | 2009-08-20 | Proteome Systems Intellectual Property Pty Ltd | Novel Methods of Diagnosis of Treatment of P. Aeruginosa Infection and Reagents Therefor |
CA2706732A1 (en) * | 2007-11-30 | 2009-06-11 | Kalobios Pharmaceuticals, Inc. | Antibodies to the pcrv antigen of pseudomonas aeruginosa |
US8501179B2 (en) * | 2008-01-10 | 2013-08-06 | Shionogi & Co., Ltd. | Antibody against PcrV |
WO2010091189A1 (en) * | 2009-02-04 | 2010-08-12 | Kalobios Pharmaceuticals, Inc. | Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection |
MX2011009100A (es) | 2009-03-11 | 2011-09-27 | Shionogi & Co | Anticuerpo humanizado pcrv que tiene actividad anti-pseudomonal. |
DK2776065T3 (da) | 2011-11-07 | 2020-10-12 | Medimmune Ltd | Kombinationsterapier ved anvendelse af anti-pseudomonas-psl- og pcrv-bindende molekyler |
CA2863468A1 (en) * | 2012-03-02 | 2013-09-06 | Ablynx Nv | Pseudomonas aeruginosa pcrv binding single variable domain antibodies |
KR20200041311A (ko) | 2017-06-23 | 2020-04-21 | 노소코미얼 백신 코포레이션 | 면역원성 조성물 |
US20200283829A1 (en) * | 2017-09-29 | 2020-09-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting the risk of developing pulmonary colonization/infection by pseudomonas aeruginosa |
EA202192810A1 (ru) | 2019-06-11 | 2022-03-05 | Регенерон Фармасьютикалз, Инк. | АНТИТЕЛА К PcrV, КОТОРЫЕ СВЯЗЫВАЮТ PcrV, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНТИТЕЛА К PcrV, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
FR3114970B1 (fr) * | 2020-10-08 | 2023-06-30 | Univ Tours | Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599665A (en) | 1993-12-21 | 1997-02-04 | Mcw Research Foundation | Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection |
US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
DE69930166T2 (de) * | 1998-11-25 | 2006-12-14 | MCW Research Foundation, Inc., Milwaukee | Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen |
-
2002
- 2002-01-25 AT AT02706015T patent/ATE347374T1/de active
- 2002-01-25 US US10/496,059 patent/US7494653B2/en not_active Expired - Fee Related
- 2002-01-25 JP JP2002563954A patent/JP4355786B2/ja not_active Expired - Fee Related
- 2002-01-25 DE DE60216564T patent/DE60216564T2/de not_active Expired - Lifetime
- 2002-01-25 DK DK02706015T patent/DK1353688T3/da active
- 2002-01-25 ES ES02706015T patent/ES2275840T3/es not_active Expired - Lifetime
- 2002-01-25 EP EP02706015A patent/EP1353688B1/de not_active Expired - Lifetime
- 2002-01-25 WO PCT/US2002/002382 patent/WO2002064161A2/en active IP Right Grant
-
2009
- 2009-01-16 US US12/355,614 patent/US8101347B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE347374T1 (de) | 2006-12-15 |
US20090191241A1 (en) | 2009-07-30 |
DE60216564T2 (de) | 2007-10-11 |
US20050063985A1 (en) | 2005-03-24 |
JP2005500250A (ja) | 2005-01-06 |
WO2002064161A9 (en) | 2002-10-31 |
US7494653B2 (en) | 2009-02-24 |
WO2002064161A3 (en) | 2002-12-12 |
US8101347B2 (en) | 2012-01-24 |
WO2002064161A2 (en) | 2002-08-22 |
ES2275840T3 (es) | 2007-06-16 |
JP4355786B2 (ja) | 2009-11-04 |
EP1353688B1 (de) | 2006-12-06 |
EP1353688A2 (de) | 2003-10-22 |
DE60216564D1 (de) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1049488T3 (da) | Fremgangsmåde og præparat til immunisering med Pseudomonas aeruginosa-V-antigenet | |
DK1353688T3 (da) | Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet | |
DK0865297T3 (da) | Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf | |
EP1285271A4 (de) | Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens(04.12.03) | |
LU91732I2 (fr) | Menveo- oligosaccharide méningococcique du group A conjugué à la protéine CRM197 de Corynebacterium diphteriae. | |
SE0001275D0 (sv) | Öronpropp | |
AU2002352394A1 (en) | Focussed antibody technology | |
DK1535068T3 (da) | Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekreter | |
DK2133100T3 (da) | MTB32A-Antigen af Mycobacterium tuberculosis med inaktiveret aktivt sted og fusionsproteiner deraf | |
HUP0303655A2 (hu) | Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk | |
UA92721C2 (ru) | Обогащенная популяция антител, высокоспецифических к антигену поверхностного полисахарида липоарабиноманана (lam) микобактерии, способ выявления микобактериальной инфекции в образце и набор для выявления микобактериальной инфекции | |
ATE244578T1 (de) | Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit | |
DK1471936T3 (da) | HIV-Vaccine og fremgangsmåde til anvendelse | |
DE60218662D1 (de) | Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine | |
AP2001002073A0 (en) | Neutralizing antibody and immunomodulatory enhancing compositions | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
WO2003006665A8 (en) | Lawsonia intracellularis | |
DE60220642D1 (de) | Perylenequinone zur anwendung mit immunotherapeutischen mitteln | |
WO2003006055A3 (en) | Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit | |
EP0836480A4 (de) | Zusammensetzungen, welche adp-ribosyltransferase-aktivität ausweisen und methoden für ihre herstellung und die verwendung derselben | |
ATE206138T1 (de) | Helicobacter pylori antigen | |
DE60229624D1 (de) | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion | |
ATE375170T1 (de) | Adjuvanskombinationen zur immunisierung und vakzine | |
WO2002030321A3 (en) | Bird diagnostics and treatments | |
UA4478U (uk) | Спосіб діагностики ефективності фототерапії |